MedTrace Logo

Pathophysiology of Post Amputation Pain

NCT01632709 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2015-07-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see how Post Amputation Pain (PAP) affects the body and brain by using sensory testing (such as pinprick testing), taking pictures of your brain (using a functional magnetic resonance imaging (fMRI) machine) and biomedical interventions (such as an injection of pain medicine). All medicines and the fMRI machine used during this study are FDA approved. The investigators hope that by learning the causes of PAP, the investigators can help future amputees.

Conditions

  • Amputation Stumps
  • Neuroma

Interventions

DRUG

Bupivacaine

one injection of 10ml of .25%

DRUG

Placebo

Dry needling

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Northwestern University

    collaborator OTHER

  • Shirley Ryan AbilityLab

    lead OTHER

Principal Investigators

  • Norman Harden, M.D. · Shirley Ryan AbilityLab

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-10-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01632709 on ClinicalTrials.gov